UNSPSC 51292014: Medifoxamine

This classification denotes a serotonin agonist and dopamine agonist with the molecular formula C16H19NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KWU7C2A1NT, chemically known as n,n-dimethyl-2,2-diphenoxyethylamine but generally known as medifoxamine, which bears US NIH Compound Identifier 36109. European Medicines Agency schedules Medifoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08693MIG. The term MEDIFOXAMINE is an International Non-Proprietary Name.

UNSPSC 51292014 Medifoxamine is a Commodity code, but the recent state and local procurement activity tagged under it reflects a significant mismatch between the code's nominal scope and actual buying patterns. Seminole County, Florida solicited naloxone and safe drug deactivation systems through an IFB in mid-2023, yet naloxone and drug deactivation equipment are not pharmaceutical compounds aligned with the medifoxamine classification. The code shows limited recent activity in state and local procurement, and the single posted opportunity appears to reflect a data-tagging error rather than genuine medifoxamine procurement demand.

The Seminole County naloxone IFB (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, with quarterly shipments and all shipping costs included in vendor proposals. The procurement included standard compliance requirements—drug-free workplace certification, E-Verify verification, workers' compensation and general liability insurance, and a three-month probationary termination clause—and was potentially funded through FEMA, which introduced Clean Air Act and Federal Water Pollution Control Act compliance obligations. The contract offered an initial two-year term with a one-year renewal option. This single opportunity, drawn from a county public-health procurement process, does not provide a representative window into genuine medifoxamine buying patterns in state and local government. The code does not currently reflect reliable demand signal for business development purposes.